
ANG Lifesciences India Ltd is Rated Strong Sell
2026-02-19 10:10:50ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 June 2023. However, the analysis and financial metrics presented here reflect the stock’s current position as of 19 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
ANG Lifesciences Q3 FY26: Losses Deepen Amid Persistent Revenue Decline
2026-02-16 14:04:34ANG Lifesciences India Limited, a micro-cap pharmaceutical company with a market capitalisation of ₹33.00 crores, reported a quarterly net loss of ₹4.75 crores for Q3 FY26 ended December 2025, marking a 61.02% sequential deterioration from the previous quarter's loss of ₹2.95 crores. On a year-on-year basis, losses expanded 8.48% from ₹5.19 crores in Q3 FY25, as the company grapples with a sustained revenue contraction and negative operating margins.
Read full news article
ANG Lifesciences India Ltd is Rated Strong Sell
2026-02-07 10:10:32ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 June 2023. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 07 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news articleWhen is the next results date for ANG Lifesciences India Ltd?
2026-02-06 23:18:59ANG Lifesciences India Ltd is scheduled to declare its results on 14 February 2026....
Read full news article
ANG Lifesciences India Ltd is Rated Strong Sell
2025-12-26 15:13:06ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 Jun 2023. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 December 2025, providing investors with the latest insights into its performance and outlook.
Read full news articleApproval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2025
14-Feb-2026 | Source : BSEUnaudited Financial Results 31.12.2025.
Board Meeting Outcome for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2025
14-Feb-2026 | Source : BSEApproval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2025
Compliances-Reg.24(A)-Annual Secretarial Compliance
06-Feb-2026 | Source : BSERevised Annual Secretarial Report for the year ended 31.03.2025.
Corporate Actions
No Upcoming Board Meetings
ANG Lifesciences India Ltd has declared 10% dividend, ex-date: 02 Nov 21
No Splits history available
ANG Lifesciences India Ltd has announced 1:4 bonus issue, ex-date: 13 Jul 22
No Rights history available






